The New England Compounding Center in Framingham, Mass., is being eyed as the manufacturer of steroid drugs that is thought to be the cause of a widening outbreak of fungal meningitis.
“U.S. health officials on Sunday reported an additional 27 cases in a fungal meningitis outbreak linked to steroid injections that has killed seven people and now affected 91 in nine states,” CNBC reported. “The U.S. Centers for Disease Control and Prevention (CDC) reported a new total of 91 cases in an update on its website, up from 64 on Saturday. Most of the new cases were reported in Michigan, where the total increased to 20 from five. Virginia’s total increased to 18 from 11.”
The New England Compounding Center, which this summer shipped more than 17,000 vials of the steroid used to reduce pain, has issued a voluntary recall “of all of its products, calling the move a precautionary measure. In a news release, it said that the move was taken out of an abundance of caution because of the risk of contamination, and that there is no indication that any other products have been contaminated”
As of Monday the cases increased to over 100 and an additional death.
- New Report Documents a Decade of Safety Violations by Compounding Pharmacies
- Keep Children Away From Pigs At Fairs Because Swine Flu Cases Increasing Rapidly
- Chester Nursing Home Fined For Incidents Of Abuse
- CDC Data Show High Incidence Of Food-borne Illness Outbreaks In Connecticut
- Ginger Helps To Reduce Pain And Help Arthritis Sufferers
- FDA Urged To Remove Over-The-Counter Teething Medications For Infants